In IL-37 transgenic mice with BDL-induced liver fibrosis, reduced expression levels of early liver fibrosis markers, such as C-X-C Motif Chemokine Ligand 2, were observed, along with decreased collagen deposition and liver fibrosis. The gene discussed is IL37; the disease is Hepatic fibrosis.